Ozempic, with its active ingredient Semaglutide, is a GLP-1 receptor agonist that supports better insulin regulation and appetite control
These findings resonate strongly with consumers focused on weight management, heart health, and long-term vitality, encouraging repeat purchases and fostering brand loyalty
At SmithRx, we partner with care support experts like 9amHealth and Form Health to support members on their weight management and type 2 diabetes journeys
A systematic review indicated that patients treated with GLP-1RAs had a significantly lower risk of incident HCC compared to those receiving other antidiabetic medications, such as insulin and sulfonylureas (Sha et al., 2024)
Concerns about muscle loss while on GLP-1s are real, so its important to talk with a healthcare provider about your eating and exercise plan to make sure that even as youre losing weight you continue to get adequate nutrition (focusing on protein and nutrient dense foods) and stave off muscle loss